Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2222 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

BioTime wins $4.7m grant from CIRM

BioTime, a biotechnology company, has reported that the California Institute for Regenerative Medicine, or CIRM, has approved a grant to the company of $4.7m to fund research related

PerkinElmer acquires Analytica of Branford

With the completion of this acquisition, PerkinElmer is expected to gain significant insight and intellectual property in the field of mass spectrometry (MS) and ion source technology. PerkinElmer